Trials / Completed
CompletedNCT02010112
Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori
Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 193 (actual)
- Sponsor
- Meridian Bioscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A new method of breath collection for testing for Helicobacter Pylori infection has been developed by Exalenz. In this study, it will be compared to the gold standard- endoscopy results to prove its accuracy.
Detailed description
This study will validate a breath collection method by comparing a newly developed breath test kit, IDkit:Hp™ TWO using breath collection bags, to congruent biopsy results (a composite reference standard by analyzing specimens with microbial culture, histological examination and rapid urease test- RUT) in detecting H.Pylori
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Breath Test Collection bags | Breath Collection bags will be used to collect breath of subjects before and after ingestion of 13-C breath test substrate |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2013-12-12
- Last updated
- 2022-12-20
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02010112. Inclusion in this directory is not an endorsement.